Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 11Nasopharyngeal Carcinoma 5Nasopharyngeal Neoplasms 3Colorectal Neoplasms 3Breast Neoplasms 3Uterine Cervical Neoplasms 2Sarcoma 2Recurrence 2Unresectable Non-small Cell Lung Cancer 1Squamous Non-small Cell Lung Cancer 1Squamous Non-Small Cell Lung Cancer SqNSCLC 1Optic Nerve Glioma 1Neuroma, Acoustic 1Neurofibromatosis 2 1Neuroblastoma 1Neoplasms 1Melanoma 1Lymphoma, T-Cell 1Lung Neoplasms 1Locally Advanced Squamous Non-small Cell Lung Cancer 1Head and Neck Neoplasms 1Glioblastoma 1Gastrointestinal Neoplasms 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Carcinoma, Hepatocellular 1Advanced Pancreatic Cancer 1Adenoma, Islet Cell 1

Interventions

Gemcitabine 6130-nm albumin-bound paclitaxel 5Albumin-Bound Paclitaxel 4Taxes 3S 1 (combination) 3Drug Therapy 2toripalimab 1surufatinib 1paricalcitol 1nimotuzumab 1irinotecan sucrosofate 1gimeracil 1envafolimab 1endostar protein 1camrelizumab 1cabiralizumab 1apatinib 1Tegafur 1Radiosurgery 1Oxaliplatin 1Nivolumab 1Leucovorin 1Irinotecan 1Immunotherapy 1IMM-101 1Fluorouracil 1Endostatins 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Advanced Pancreatic Cancer × Endostatins × Clear all
NCT05298020 2022-03-28

Envafolimab Combined With Endostar and Chemotherapy for First-line Treatment of Advanced Pancreatic Cancer

The Affiliated Hospital of Xuzhou Medical University

Phase 2 Unknown
20 enrolled
Gastrointestinal

Advanced Pancreatic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡